A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization.

Journal: Kidney international
PMID:

Abstract

Lesion scores on procurement donor biopsies are commonly used to guide organ utilization for deceased-donor kidneys. However, frozen sections present challenges for histological scoring, leading to inter- and intra-observer variability and inappropriate discard. Therefore, we constructed deep-learning based models to recognize kidney tissue compartments in hematoxylin & eosin-stained sections from procurement needle biopsies performed nationwide in years 2011-2020. To do this, we extracted whole-slide abnormality features from 2431 kidneys and correlated with pathologists' scores and transplant outcomes. A Kidney Donor Quality Score (KDQS) was derived and used in combination with recipient demographic and peri-transplant characteristics to predict graft loss or assist organ utilization. The performance on wedge biopsies was additionally evaluated. Our model identified 96% and 91% of normal/sclerotic glomeruli respectively; 94% of arteries/arterial intimal fibrosis; 90% of tubules. Whole-slide features of Sclerotic Glomeruli (GS)%, Arterial Intimal Fibrosis (AIF)%, and Interstitial Space Abnormality (ISA)% demonstrated strong correlations with corresponding pathologists' scores of all 2431 kidneys, but had superior associations with post-transplant estimated glomerular filtration rates in 2033 and graft loss in 1560 kidneys. The combination of KDQS and other factors predicted one- and four-year graft loss in a discovery set of 520 kidneys and a validation set of 1040 kidneys. By using the composite KDQS of 398 discarded kidneys due to "biopsy findings", we suggest that if transplanted, 110 discarded kidneys could have had similar survival to that of other transplanted kidneys. Thus, our composite KDQS and survival prediction models may facilitate risk stratification and organ utilization while potentially reducing unnecessary organ discard.

Authors

  • Zhengzi Yi
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Caixia Xi
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Madhav C Menon
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Nephrology Division, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Paolo Cravedi
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Fasika Tedla
    The Recanati/Miller Transplantation Institute (RMTI), Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Alan Soto
    Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Zeguo Sun
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Keyu Liu
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York New York, USA.
  • Jason Zhang
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York New York, USA.
  • Chengguo Wei
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Man Chen
    Nanjing Institute of Agricultural Mechanization, Ministry of Agriculture and Rural Affairs, Nanjing 210014, China.
  • Wenlin Wang
    Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York New York, USA.
  • Brandon Veremis
    Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Monica Garcia-Barros
    Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Abhishek Kumar
    Manipal Academy of Higher Education (MAHE), Manipal, India.
  • Danielle Haakinson
    Nephrology Division, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Rachel Brody
    Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Evren U Azeloglu
    Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lorenzo Gallon
    Northwestern Medicine Organ Transplantation Center, Northwestern University, Chicago, Illinois, USA.
  • Philip O'Connell
    Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  • Maarten Naesens
    Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Ron Shapiro
    Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, NY, USA.
  • Robert B Colvin
    Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
  • Stephen Ward
    Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: stephen.ward@mountsinai.org.
  • Fadi Salem
    Pathology Division, Department of Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Weijia Zhang